237 related articles for article (PubMed ID: 23852985)
1. The trade-off between costs and quality of care in the treatment of psychosomatic patients with somatoform pain disorder.
Haas L; Stargardt T; Schreyoegg J; Schlösser R; Klapp BF; Danzer G
Appl Health Econ Health Policy; 2013 Aug; 11(4):359-68. PubMed ID: 23852985
[TBL] [Abstract][Full Text] [Related]
2. Introduction of DRG-based reimbursement in inpatient psychosomatics--an examination of cost homogeneity and cost predictors in the treatment of patients with eating disorders.
Haas L; Stargardt T; Schreyoegg J; Schlösser R; Hofmann T; Danzer G; Klapp BF
J Psychosom Res; 2012 Nov; 73(5):383-90. PubMed ID: 23062813
[TBL] [Abstract][Full Text] [Related]
3. Testing minimal clinically important difference: consensus or conundrum?
Gatchel RJ; Mayer TG
Spine J; 2010 Apr; 10(4):321-7. PubMed ID: 20362248
[TBL] [Abstract][Full Text] [Related]
4. The societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costs.
Langley PC
J Med Econ; 2012; 15(6):1201-15. PubMed ID: 22835007
[TBL] [Abstract][Full Text] [Related]
5. Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease.
Parker SL; Mendenhall SK; Shau D; Adogwa O; Cheng JS; Anderson WN; Devin CJ; McGirt MJ
J Neurosurg Spine; 2012 Jan; 16(1):61-7. PubMed ID: 21962034
[TBL] [Abstract][Full Text] [Related]
6. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of multilevel hemilaminectomy for lumbar stenosis-associated radiculopathy.
Parker SL; Fulchiero EC; Davis BJ; Adogwa O; Aaronson OS; Cheng JS; Devin CJ; McGirt MJ
Spine J; 2011 Aug; 11(8):705-11. PubMed ID: 21641874
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
9. Health care resource use associated with integrated psychological treatment.
Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
[TBL] [Abstract][Full Text] [Related]
10. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
Haro H; Maekawa S; Hamada Y
Spine J; 2008; 8(2):380-4. PubMed ID: 17433781
[TBL] [Abstract][Full Text] [Related]
11. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
[TBL] [Abstract][Full Text] [Related]
12. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
14. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
Fischer F; Hoffmann K; Mönter N; Walle M; Beneke R; Negenborn S; Weinmann S; Willich SN; Berghöfer A
Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
[TBL] [Abstract][Full Text] [Related]
15. Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis.
Parker SL; Adogwa O; Mendenhall SK; Shau DN; Anderson WN; Cheng JS; Devin CJ; McGirt MJ
Spine J; 2012 Dec; 12(12):1122-8. PubMed ID: 23158968
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of psychosomatic inpatient treatment for somatoform disorders: results of a multicenter study].
Beutel ME; von Heymann F; Bleichner F; Tritt K; Hardt J
Z Psychosom Med Psychother; 2014; 60(1):17-24. PubMed ID: 24615235
[TBL] [Abstract][Full Text] [Related]
17. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
18. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
Zámbori J; Szádóczky E; Rózsa S; Füredi J
J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
[TBL] [Abstract][Full Text] [Related]
19. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
Stäbler W; Wagner B
Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
[TBL] [Abstract][Full Text] [Related]
20. [Effects and cost-effectiveness analysis of inpatient treatment for somatoform disorders].
Hiller W; Kroymann R; Leibbrand R; Cebulla M; Korn HJ; Rief W; Fichter MM
Fortschr Neurol Psychiatr; 2004 Mar; 72(3):136-46. PubMed ID: 14999593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
